Robert D. King - 29 Aug 2025 Form 4 Insider Report for Corteva, Inc. (CTVA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Sep 2025, 17:20:18 UTC
Prior SEC filing
08 Apr 2025
Next SEC filing
29 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Abigail Jarrell, by power-of-attorney

Key filing fact

Robert D. King filed Form 4 for Corteva, Inc. (CTVA) on 02 Sep 2025.

Key facts

  • This page summarizes Robert D. King's Form 4 filing for Corteva, Inc. (CTVA).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Sep 2025, 17:20.

Change

  • Previous filing in this sequence was filed on 08 Apr 2025.
  • Current net transaction value: -$1,306,688.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001921979 Primary reporting owner

King Robert D.

Relationship
EVP, Crop Protection Business
Address
C/O CORTEVA, INC., 9330 ZIONSVILLE ROAD, INDIANAPOLIS
Signature
/s/Abigail Jarrell, by power-of-attorney
Signature date
02 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTVA transaction

Common Stock

Options Exercise

Transaction value
$877,703
Shares
+14,960
Change %
+24%
Price
$58.67
Shares after
77,180
Date
29 Aug 2025
Ownership
Direct
CTVA transaction

Common Stock

Options Exercise

Transaction value
$581,602
Shares
+9,337
Change %
+12%
Price
$62.29
Shares after
86,517
Date
29 Aug 2025
Ownership
Direct
CTVA transaction

Common Stock

Sale

Transaction value
$2,765,993
Shares
-37,280
Change %
-43%
Price
$74.20
Shares after
49,262
Date
29 Aug 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTVA transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-14,960
Change %
-100%
Price
$0.000000
Shares after
0
Date
29 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,960
Exercise price
$58.67
Footnotes
F3
CTVA transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
$0
Shares
-9,337
Change %
-67%
Price
$0.000000
Shares after
4,669
Date
29 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,337
Exercise price
$62.29
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $74.17 to $74.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

Includes acquisition of 25.3808 shares pursuant to dividend reinvestment.

Footnote F3

The options became fully exercisable on April 4, 2025, the third anniversary of the grant date.

Footnote F4

One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025, and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .